| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | President &CSO
1 company
Shacham Sharon is a Chief Scientific Officer at Karyopharm Therapeutics Inc.. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $8.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 10, 2019 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 20,000 | $16.51 | $330,106.00 | -1.6% | |
| Nov 11, 2019 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 20,000 | $14.69 | $293,864.00 | -1.6% | |
| Nov 1, 2019 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 20,000 | $12.00 | $240,000.00 | -1.6% | |
| Sep 16, 2019 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 20,000 | $12.00 | $240,000.00 | -1.6% | |
| Jan 7, 2019 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 12,500 | $10.23 | $127,823.75 | -1.7% | |
| Dec 7, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 12,500 | $10.11 | $126,422.50 | -1.7% | |
| Nov 26, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 9,600 | $11.00 | $105,600.00 | -1.8% | |
| Nov 19, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 400 | $11.14 | $4,454.52 | - | |
| Nov 7, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 12,500 | $11.65 | $145,592.50 | -1.7% | |
| Oct 18, 2018 | KPTI Karyopharm Therapeutics Inc. | President &CSO | Sale+OE | 10,000 | $12.63 | $126,304.00 | -1.9% |